Gary Monheit, MD
MOHS-Micrographic Surgery · Birmingham, ALNPI 1942230248
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $24,300 of the $37,193 with a category attached, or 65.3%. Merz North America, Inc. accounts for 74.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $36,218 and has fallen 99.8% since, to $57 in 2024.
Across 58 payments — averaging $641.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$28K
- AbbVie$9K
- Sanofi$71
- Genentech USA, Inc.$51
- Galderma Laboratories, L.p.$39
- Incyte Corporation$30
- plus $117 from 6 others
Across 48 payments — averaging $3627.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$174K
What the payments were for
- Consulting fees$24,30065%
- Travel & lodging$10,55728%
- Food & beverage$2,2156%
- Education$1210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 11 | $27,872 |
| AbbVie(2 entities) | 31 | $9,014 |
| Sanofi | 3 | $71 |
| Genentech USA, Inc. | 4 | $51 |
| Galderma Laboratories, L.p. | 2 | $39 |
| Incyte Corporation | 1 | $30 |
| UCB, Inc. | 1 | $26 |
| Dermira, Inc. | 1 | $21 |
| Amgen | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$26,518
- BOTOX COSMETIC$8,499
- BOTOX$105
How this compares
Too few mohs-micrographic surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 21 | $166 |
| Cephalexin | 42 | $123 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Birmingham
- Michael HadleyBirmingham$3K
- Bailey TayebiBirmingham$3K
- Conway HuangBirmingham$3K
- Michael FranzettiBirmingham$2K
- Evans BaileyBirmingham$1K
- Carlton PhillipsBirmingham$608
- Jeffrey StrickerDothan$10K
- Adam RichardsonNorthport$8K
- Albert RiveraMadison$6K
- Vernon ForresterMadison$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.